• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症:发病机制与治疗策略

Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.

作者信息

Jimenez-Sanchez Maria, Licitra Floriana, Underwood Benjamin R, Rubinsztein David C

机构信息

Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 0XY, United Kingdom.

Department of Old Age Psychiatry, Beechcroft, Fulbourn Hospital, Cambridge CB21 5EF, United Kingdom.

出版信息

Cold Spring Harb Perspect Med. 2017 Jul 5;7(7):a024240. doi: 10.1101/cshperspect.a024240.

DOI:10.1101/cshperspect.a024240
PMID:27940602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5495055/
Abstract

Huntington's disease is a late-onset neurodegenerative disease caused by a CAG trinucleotide repeat in the gene encoding the huntingtin protein. Despite its well-defined genetic origin, the molecular and cellular mechanisms underlying the disease are unclear and complex. Here, we review some of the currently known functions of the wild-type huntingtin protein and discuss the deleterious effects that arise from the expansion of the CAG repeats, which are translated into an abnormally long polyglutamine tract. Finally, we outline some of the therapeutic strategies that are currently being pursued to slow down the disease.

摘要

亨廷顿舞蹈症是一种迟发性神经退行性疾病,由编码亨廷顿蛋白的基因中的CAG三核苷酸重复序列引起。尽管其遗传起源明确,但该疾病背后的分子和细胞机制尚不清楚且复杂。在这里,我们回顾了野生型亨廷顿蛋白目前已知的一些功能,并讨论了CAG重复序列扩增所产生的有害影响,这种扩增会转化为异常长的聚谷氨酰胺链。最后,我们概述了目前正在探索的一些减缓该疾病的治疗策略。

相似文献

1
Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.亨廷顿舞蹈症:发病机制与治疗策略
Cold Spring Harb Perspect Med. 2017 Jul 5;7(7):a024240. doi: 10.1101/cshperspect.a024240.
2
Huntington's disease: from pathology and genetics to potential therapies.亨廷顿舞蹈病:从病理学、遗传学至潜在疗法
Biochem J. 2008 Jun 1;412(2):191-209. doi: 10.1042/BJ20071619.
3
Autopsy-proven Huntington's disease with 29 trinucleotide repeats.经尸检证实的亨廷顿舞蹈症,具有29个三核苷酸重复序列。
Mov Disord. 2007 Jan;22(1):127-30. doi: 10.1002/mds.21195.
4
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease.针对亨廷顿舞蹈病体细胞不稳定性的治疗的CAG重复阈值。
Brain. 2024 May 3;147(5):1784-1798. doi: 10.1093/brain/awae063.
5
Huntington's disease: from molecular pathogenesis to clinical treatment.亨廷顿病:从分子发病机制到临床治疗。
Lancet Neurol. 2011 Jan;10(1):83-98. doi: 10.1016/S1474-4422(10)70245-3.
6
Molecular aspects of Huntington's disease.亨廷顿舞蹈症的分子层面
J Neurosci Res. 1998 Nov 1;54(3):301-8. doi: 10.1002/(SICI)1097-4547(19981101)54:3<301::AID-JNR1>3.0.CO;2-W.
7
Huntingtin-protein interactions and the pathogenesis of Huntington's disease.亨廷顿蛋白相互作用与亨廷顿舞蹈症的发病机制
Trends Genet. 2004 Mar;20(3):146-54. doi: 10.1016/j.tig.2004.01.008.
8
Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice.不间断的 CAG 重复驱动人类亨廷顿 BAC 小鼠纹状体选择性转录病和核发病。
Neuron. 2022 Apr 6;110(7):1173-1192.e7. doi: 10.1016/j.neuron.2022.01.006. Epub 2022 Feb 2.
9
Genetics and neuropathology of Huntington's disease.亨廷顿病的遗传学和神经病理学。
Int Rev Neurobiol. 2011;98:325-72. doi: 10.1016/B978-0-12-381328-2.00014-6.
10
How does the Huntington's disease mutation damage cells?亨廷顿舞蹈症突变是如何损害细胞的?
Sci Aging Knowledge Environ. 2003 Sep 17;2003(37):PE26. doi: 10.1126/sageke.2003.37.pe26.

引用本文的文献

1
Melatonin-A Powerful Antioxidant in Neurodegenerative Diseases.褪黑素——神经退行性疾病中的一种强大抗氧化剂。
Antioxidants (Basel). 2025 Jul 3;14(7):819. doi: 10.3390/antiox14070819.
2
The Rab3 family proteins in age-related neurodegeneration: unraveling molecular pathways and potential therapeutic targets.Rab3家族蛋白与年龄相关性神经退行性变:解析分子途径及潜在治疗靶点
NPJ Aging. 2025 Jul 14;11(1):64. doi: 10.1038/s41514-025-00257-6.
3
Mesenchymal Stem Cell-Derived Extracellular Vesicles: Emerging Therapies for Neurodegenerative Diseases.间充质干细胞衍生的细胞外囊泡:神经退行性疾病的新兴疗法
Int J Nanomedicine. 2025 Jul 2;20:8547-8565. doi: 10.2147/IJN.S526945. eCollection 2025.
4
Barbigerone attenuates 3-nitropropionic acid-induced Huntington's disease-like neuropathology in rats via antioxidant, anti-inflammatory, and neuroprotective mechanisms.巴贝吉酮通过抗氧化、抗炎和神经保护机制减轻3-硝基丙酸诱导的大鼠亨廷顿氏病样神经病理学。
Sci Rep. 2025 Jul 2;15(1):23356. doi: 10.1038/s41598-025-07181-5.
5
Engine breakdown of lysosomes and related organelles and the resulting physiology.溶酶体及相关细胞器的功能障碍及其引发的生理学变化。
Front Cell Dev Biol. 2025 Jun 16;13:1575571. doi: 10.3389/fcell.2025.1575571. eCollection 2025.
6
Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges.外泌体作为用于脑靶向递送治疗性核酸的纳米载体:进展与挑战
J Nanobiotechnology. 2025 Jun 18;23(1):453. doi: 10.1186/s12951-025-03528-2.
7
Application of Natural Products in Neurodegenerative Diseases by Intranasal Administration: A Review.天然产物经鼻内给药在神经退行性疾病中的应用:综述
Pharmaceutics. 2025 May 20;17(5):675. doi: 10.3390/pharmaceutics17050675.
8
Role of Antioxidants in Modulating the Microbiota-Gut-Brain Axis and Their Impact on Neurodegenerative Diseases.抗氧化剂在调节微生物群-肠-脑轴中的作用及其对神经退行性疾病的影响。
Int J Mol Sci. 2025 Apr 12;26(8):3658. doi: 10.3390/ijms26083658.
9
Mitochondria and Endoplasmic Reticulum Contact Site as a Regulator of Proteostatic Stress Responses in Neurodegenerative Diseases.线粒体与内质网接触位点作为神经退行性疾病中蛋白质稳态应激反应的调节因子
Bioessays. 2025 May 4:e70016. doi: 10.1002/bies.70016.
10
Decoding the genetic blueprints of neurological disorders: disease mechanisms and breakthrough gene therapies.解码神经疾病的基因蓝图:疾病机制与突破性基因疗法
Front Neurol. 2025 Apr 11;16:1422707. doi: 10.3389/fneur.2025.1422707. eCollection 2025.

本文引用的文献

1
Prion-Like Characteristics of Polyglutamine-Containing Proteins.聚谷氨酰胺蛋白的朊病毒样特征。
Cold Spring Harb Perspect Med. 2018 Feb 1;8(2):a024257. doi: 10.1101/cshperspect.a024257.
2
siRNA screen identifies QPCT as a druggable target for Huntington's disease.siRNA 筛选鉴定 QPCT 为亨廷顿病的可用药靶标。
Nat Chem Biol. 2015 May;11(5):347-354. doi: 10.1038/nchembio.1790. Epub 2015 Apr 6.
3
Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease.在亨廷顿舞蹈症的小鼠和细胞模型中,突变型亨廷顿蛋白的核周包涵体破坏核膜会导致细胞周期重新进入和纹状体细胞死亡。
Hum Mol Genet. 2015 Mar 15;24(6):1602-16. doi: 10.1093/hmg/ddu574. Epub 2014 Nov 14.
4
Potential function for the Huntingtin protein as a scaffold for selective autophagy.亨廷顿蛋白作为选择性自噬支架的潜在功能。
Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16889-94. doi: 10.1073/pnas.1420103111. Epub 2014 Nov 10.
5
Mutant huntingtin alters Tau phosphorylation and subcellular distribution.突变型亨廷顿蛋白改变Tau蛋白磷酸化及亚细胞分布。
Hum Mol Genet. 2015 Jan 1;24(1):76-85. doi: 10.1093/hmg/ddu421. Epub 2014 Aug 20.
6
Huntington's disease is a four-repeat tauopathy with tau nuclear rods.亨廷顿病是一种四重复tau 病,具有 tau 核棒。
Nat Med. 2014 Aug;20(8):881-5. doi: 10.1038/nm.3617. Epub 2014 Jul 20.
7
Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons.突变亨廷顿蛋白的跨神经元传播导致神经元中非细胞自主的病理学改变。
Nat Neurosci. 2014 Aug;17(8):1064-72. doi: 10.1038/nn.3761. Epub 2014 Jul 13.
8
Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits.亨廷顿蛋白对于皮质和纹状体回路中正常兴奋性突触发育是必需的。
J Neurosci. 2014 Jul 9;34(28):9455-72. doi: 10.1523/JNEUROSCI.4699-13.2014.
9
Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.TrkB受体信号传导受损是亨廷顿舞蹈病中皮质纹状体功能障碍的基础。
Neuron. 2014 Jul 2;83(1):178-88. doi: 10.1016/j.neuron.2014.05.032.
10
Inhibition of mitochondrial protein import by mutant huntingtin.突变型亨廷顿蛋白抑制线粒体蛋白的输入。
Nat Neurosci. 2014 Jun;17(6):822-31. doi: 10.1038/nn.3721. Epub 2014 May 18.